(Q28280931)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

Metabotropic glutamate receptors in the basal ganglia motor circuit (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Ferdinando Nicoletti

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1

P Jeffrey Conn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Michael J Marino

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 October 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276355%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Neuroscience

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

787-798

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276355%20AND%20SRC:MED&resulttype=core&format=json

Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins

9 January 2020

cites work

1 reference

Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function.

21 April 2017

1 reference

Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS

21 April 2017

1 reference

Addiction and the brain: The neurobiology of compulsion and its persistence

21 April 2017

1 reference

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

21 April 2017

1 reference

21 April 2017

1 reference

The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat

21 April 2017

1 reference

Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment

21 April 2017

1 reference

Pharmacology and functions of metabotropic glutamate receptors

21 April 2017

1 reference

Functional and pathophysiological models of the basal ganglia

21 April 2017

1 reference

Striatal interneurones: chemical, physiological and morphological characterization

21 January 2018

1 reference

Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states

21 January 2018

1 reference

GABA(B) and group I metabotropic glutamate receptors in the striatopallidal complex in primates

21 January 2018

1 reference

Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons

21 January 2018

1 reference

Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases

21 January 2018

1 reference

Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons.

21 January 2018

1 reference

Permissive role of adenosine A2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum.

21 January 2018

1 reference

Signal transduction pathways involved in the acute potentiation of NMDA responses by 1S,3R-ACPD in rat hippocampal slices

21 January 2018

1 reference

Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems

21 January 2018

1 reference

NMDA-induced phosphorylation and regulation of mGluR5.

21 January 2018

1 reference

Selective activation of group I metabotropic glutamate receptors upregulates preprodynorphin, substance P, and preproenkephalin mRNA expression in rat dorsal striatum

21 January 2018

1 reference

Group I metabotropic glutamate receptor-mediated calcium signalling and immediate early gene expression in cultured rat striatal neurons

21 January 2018

1 reference

Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling

21 January 2018

1 reference

Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons

21 January 2018

1 reference

Plasticity of glutamatergic control of striatal acetylcholine release in experimental parkinsonism: opposite changes at group-II metabotropic and NMDA receptors.

21 January 2018

1 reference

Distinct physiological roles of the Gq-coupled metabotropic glutamate receptors Co-expressed in the same neuronal populations

21 January 2018

1 reference

Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors

21 January 2018

1 reference

Mechanism of regulation of casein kinase I activity by group I metabotropic glutamate receptors

21 January 2018

1 reference

Activation of groups I or III metabotropic glutamate receptors inhibits excitatory transmission in the rat subthalamic nucleus

21 January 2018

1 reference

Trans-1-aminocyclopentane-1,3-dicarboxylic acid (t-ACPD) decreases synaptic excitation in rat striatal slices through a presynaptic action

21 January 2018

1 reference

In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats

21 January 2018

1 reference

Metabotropic glutamate receptors depress glutamate-mediated synaptic input to rat midbrain dopamine neurones in vitro

21 January 2018

1 reference

Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum.

21 January 2018

1 reference

Activation of group III metabotropic glutamate receptors presynaptically reduces both GABAergic and glutamatergic transmission in the rat globus pallidus

21 January 2018

1 reference

Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1.

21 January 2018

1 reference

Selective involvement of mGlu1 receptors in corticostriatal LTD.

21 January 2018

1 reference

The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia

21 January 2018

1 reference

Postsynaptic endocannabinoid release is critical to long-term depression in the striatum

21 January 2018

1 reference

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

21 January 2018

1 reference

D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons

21 January 2018

1 reference

Neuronal cell death in Huntington's disease: a potential role for dopamine

21 January 2018

1 reference

The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory.

21 January 2018

1 reference

Functional surgery for Parkinson's disease treatment: a structured analysis of a decade of published literature

21 January 2018

1 reference

The role of nigrostriatal dopamine in metabotropic glutamate agonist-induced rotation

21 January 2018

1 reference

Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats.

21 January 2018

1 reference

The role of metabotropic glutamate receptors in regulation of striatal proenkephalin expression: implications for the therapy of Parkinson's disease.

21 January 2018

1 reference

Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors

21 January 2018

1 reference

Haloperidol-induced alteration in the physiological actions of group I mGlus in the subthalamic nucleus and the substantia nigra pars reticulata

21 January 2018

1 reference

Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders

21 January 2018

1 reference

Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease

21 January 2018

1 reference

Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment

21 January 2018

1 reference

Dopamine modulates the function of group II and group III metabotropic glutamate receptors in the substantia nigra pars reticulata

21 January 2018

1 reference

(-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection.

21 January 2018

1 reference

The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders

21 January 2018

1 reference

Biomedicine. Parkinson's--divergent causes, convergent mechanisms.

21 January 2018

1 reference

Are ubiquitination pathways central to Parkinson's disease?

21 January 2018

1 reference

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

21 January 2018

1 reference

Glutamatergic drugs in Parkinson's disease

21 January 2018

1 reference

Blockade of 1-methyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication or MK-801 treatment: a stereological estimate of neuronal loss

21 January 2018

1 reference

Blockade of subthalamic glutamatergic activity corrects changes in neuronal metabolism and motor behavior in rats with nigrostriatal lesions.

21 January 2018

1 reference

Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's disease

21 January 2018

1 reference

Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.

21 January 2018

1 reference

Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP.

21 January 2018

1 reference

Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes

21 January 2018

1 reference

Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction

21 January 2018

1 reference

DCG-IV but not other group-II metabotropic receptor agonists induces microglial BDNF mRNA expression in the rat striatum. Correlation with neuronal injury.

21 January 2018

1 reference

Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.

21 January 2018

1 reference

Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways.

21 January 2018

1 reference

Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neurons

21 January 2018

1 reference

Experimental therapeutics in transgenic mouse models of Huntington's disease

21 January 2018

1 reference

Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission

21 January 2018

1 reference

Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid-induced striatal toxicity: involvement of pre- and post-synaptic mechanisms and lack of direct NMDA blocking activity

21 January 2018

1 reference

The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity

21 January 2018

1 reference

Mitochondrial defect in Huntington's disease caudate nucleus

21 January 2018

1 reference

Bioenergetics and glutamate excitotoxicity

21 January 2018

1 reference

Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene

21 January 2018

1 reference

Models of basal ganglia function and pathophysiology of movement disorders.

21 January 2018

1 reference

Modulation of the basal ganglia by metabotropic glutamate receptors: potential for novel therapeutics

31 March 2020

1 reference

Glutamate receptors and Parkinson's disease: opportunities for intervention

31 March 2020

1 reference

The metabotropic glutamate receptors: structure, activation mechanism and pharmacology

31 March 2020

1 reference

Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum.

31 March 2020

1 reference

Firing patterns and synaptic potentials of identified giant aspiny interneurons in the rat neostriatum.

31 March 2020

1 reference

The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons.

31 March 2020

1 reference

Interactions between ephrin-B and metabotropic glutamate 1 receptors in brain tissue and cultured neurons.

31 March 2020

1 reference

Mechanisms and functions of Eph and ephrin signalling

31 March 2020

1 reference

Regulation of the nigrostriatal pathway by metabotropic glutamate receptors during development.

31 March 2020

1 reference

Quisqualate Metabotropic Receptors Modulate NMDA Currents and Facilitate Induction of Long-Term Potentiation Through Protein Kinase C

31 March 2020

1 reference

Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function.

31 March 2020

1 reference

The protein phosphatase 1/2A inhibitor okadaic acid increases CREB and Elk-1 phosphorylation and c-fos expression in the rat striatum in vivo

31 March 2020

1 reference

Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation

31 March 2020

1 reference

The modulation of calcium currents by the activation of mGluRs. Functional implications

31 March 2020

1 reference

Subthalamic nucleus neurons switch from single-spike activity to burst-firing mode.

31 March 2020

1 reference

Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus.

31 March 2020

1 reference

Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata.

31 March 2020

1 reference

Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGLuR2 or 3

31 March 2020

1 reference

Type 2 metabotropic glutamate (mGlu) receptors tonically inhibit transmitter release in rat caudate nucleus: in vivo studies with (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a new potent and selective antagonist

31 March 2020

1 reference

The origin and neuronal function of in vivo nonsynaptic glutamate.

31 March 2020

1 reference

Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata

31 March 2020

1 reference

Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse.

31 March 2020

1 reference

Activation of group III mGluRs inhibits GABAergic and glutamatergic transmission in the substantia nigra pars reticulata

31 March 2020

1 reference

Long-term synaptic depression in the striatum: physiological and pharmacological characterization

31 March 2020

1 reference

Post-receptor mechanisms underlying striatal long-term depression.

31 March 2020

1 reference

Decreased frequency but not amplitude of quantal synaptic responses associated with expression of corticostriatal long-term depression

31 March 2020

1 reference

Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses

31 March 2020

1 reference

Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity

31 March 2020

1 reference

Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine.

31 March 2020

1 reference

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

31 March 2020

1 reference

Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum

31 March 2020

1 reference

Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates

31 March 2020

1 reference

Low-dose L-dopa therapy in Parkinson's disease: a 6-year follow-up study

31 March 2020

1 reference

Surgical treatment for Parkinson's disease

31 March 2020

1 reference

Metabotropic glutamate agonist-induced rotation: a pharmacological, FOS immunohistochemical, and [14C]-2-deoxyglucose autoradiographic study

31 March 2020

1 reference

Effects of the prototypical mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats

31 March 2020

1 reference

Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism.

31 March 2020

1 reference

Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats.

31 March 2020

1 reference

Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons.

31 March 2020

1 reference

LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats.

31 March 2020

1 reference

Activation of group III metabotropic glutamate receptors in selected regions of the basal ganglia alleviates akinesia in the reserpine-treated rat.

31 March 2020

1 reference

(+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice

31 March 2020

1 reference

Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism

31 March 2020

1 reference

Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity.

31 March 2020

1 reference

Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

31 March 2020

1 reference

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

31 March 2020

1 reference

Differential subcellular localization of mGluR1a and mGluR5 in the rat and monkey Substantia nigra.

31 March 2020

1 reference

Ionotropic and metabotropic GABA and glutamate receptors in primate basal ganglia.

31 March 2020

1 reference

The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling

31 March 2020

1 reference

Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta

31 March 2020

1 reference

Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures.

31 March 2020

1 reference

Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death

31 March 2020

1 reference

Neuroprotective activity of metabotropic glutamate receptor ligands.

31 March 2020

1 reference

Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 r

31 March 2020

1 reference

Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective

31 March 2020

1 reference

Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease

31 March 2020

1 reference

Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs

31 March 2020

1 reference

Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat.

31 March 2020

1 reference

Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons

31 March 2020

1 reference

Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRN1763

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276355%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 January 2020

1022429066

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017